体外毒性検査の世界市場予測：製品＆サービス別、毒性エンドポイント＆試験別、技術別、方法別

LINEで送る

1 Introduction (Page No. – 22)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders
1.6 Limitations
2 Research Methodology (Page No. – 26)
2.1 Research Approach
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Break Down of Primaries
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary (Page No. – 34)
4 Premium Insights (Page No. – 39)
4.1 In Vitro Toxicology Testing Market Overview
4.2 Asia Pacific: Market, By Method
4.3 Market: Geographic Growth Opportunities
4.4 Market, By Region (2017–2024)
4.5 Market: Developed vs Developing Markets
5 Market Overview (Page No. – 44)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Opposition to Animal Testing
5.2.1.2 Technological Advancements
5.2.1.3 R&D Toward Early Stage Toxicity Detection
5.2.2 Market Restraints
5.2.2.1 Reluctance of Regulatory Authorities to Consider Alternative Methods for Proving Safety and Efficacy
5.2.2.2 Failure to Establish the Intricacies of in Vivo Conditions, In Vitro
5.2.2.3 Lack of In Vitro Models to Study Complex Endpoints
5.2.3 Market Opportunities
5.2.3.1 Increasing Focus on Drug Discovery and Personalized Medicine Using In Vitro Methods
5.2.3.2 Increasing Number of Toxicology Databases
5.2.4 Market Challenges
5.2.4.1 Dearth of Skilled Professionals
6 Industry Insights (Page No. – 51)
6.1 Introduction
6.2 Industry Trends
6.2.1 Increasing Focus on Predictive Toxicology
6.3 Supply Chain Analysis
6.4 Regulatory Committee Activities
6.4.1 Major Stakeholders
6.4.2 Key Influencers
7 In Vitro Toxicology Testing Market, By Product & Service (Page No. – 55)
7.1 Introduction
7.2 Consumables
7.2.1 Consumables to Dominate the Market During the Forecast Period
7.3 Assays
7.3.1 Bacterial Toxicity Assays
7.3.1.1 Bacterial Assays Dominate the Market as They Form the Most Widely Adopted Assay Type Across Industries
7.3.2 Enzyme Toxicity Assays
7.3.2.1 Enzyme Toxicity Assays are Being Increasingly Used for Endocrine-Disrupting Studies
7.3.3 Cell-Based Elisa & Western Blots
7.3.3.1 Cell-Based Assays are Cost-Effective and Witnessing Increasing Adoption in Drug Discovery
7.3.4 Receptor-Binding Assays
7.3.4.1 Receptor-Binding Assays are Well-Suited for High-Throughput Formats
7.3.5 Tissue Culture Assays
7.3.5.1 Tissue Culture Assays Offer the Advantage of Mimicking in Vivo Tissue Architecture
7.3.6 Other Assays
7.4 Equipment
7.4.1 Fully Automated Equipment is Witnessing Growing Adoption in Research
7.5 Software
7.5.1 Software Tools are Vital in Reducing Analysis Times and Managing Large Amounts of Data Generated in Operations
7.6 Services
7.6.1 Lack of Infrastructure and Expertise have Driven Reliance on Service Providers
8 In Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests (Page No. – 71)
8.1 Introduction
8.2 ADME (Absorption, Distribution, Metabolism, & Excretion)
8.2.1 ADME to Dominate the In Vitro Toxicity Testing Market During the Forecast Period
8.3 Skin Irritation, Corrosion, & Sensitization
8.3.1 This Toxicity Endpoint is Widely Studied in the Cosmetic Industry
8.4 Genotoxicity Testing
8.4.1 Genotoxic Assessment Forms an Integral Part in the Pre-Clinical Drug Development Process
8.5 Cytotoxicity Testing
8.5.1 Cytotoxic Tests are Majorly Done on Cancer and Non-Cancer Cell Lines
8.6 Ocular Toxicity
8.6.1 In Vitro and EX Vivo Methods are Gaining High Recognition for Ocular Toxicity Testing
8.7 Organ Toxicity
8.7.1 High-Content Screening and Cell-Based Assays are Used to Detect Organ-Specific Toxicity
8.8 Phototoxicity Testing
8.8.1 Validated Non-Animal Methods are Used to Evaluate Photosafety of Cosmetics, Pharmaceuticals, & Chemicals
8.9 Dermal Toxicity
8.9.1 In Vitro Methods for Dermal Toxicity Testing is Expected to Gain Recognition in the Coming Years
8.10 Other Toxicity Endpoints & Tests
9 In Vitro Toxicology Testing Market, By Technology (Page No. – 85)
9.1 Introduction
9.2 Cell Culture Technologies
9.2.1 Cell- & Tissue-Based Technologies are the Most Widely Adopted in In Vitro Testing
9.3 High-Throughput Technologies
9.3.1 Increasing Use of High-Content Imaging Technologies is Driving Market Growth
9.4 Toxicogenomics
9.4.1 Improvements in Proteomic Technologies are Enhancing the Study of Gene & Protein Activity During Toxicity Analysis
10 In Vitro Toxicology Testing Market, By Industry (Page No. – 92)
10.1 Introduction
10.2 Pharmaceuticals & Biopharmaceuticals
10.2.1 Drug Attrition Rate is Leading to the High Adoption of In Vitro Testing Assays in the Early Stages of Drug Development
10.3 Cosmetics & Household Products
10.3.1 Ban on Animal Testing is Increasing the Adoption of In Vitro Assays for Safety Testing
10.4 Food
10.4.1 Increasing Focus on Food Safety is Driving Market Growth
10.5 Chemicals
10.5.1 Increasing Focus on Organoid-Based In Vitro Approaches for Chemical Testing is Propelling the Market
11 In Vitro Toxicology Testing Market, By Method (Page No. – 101)
11.1 Introduction
11.2 Cellular Assays
11.2.1 Development of Multi-Parameter Assays Will Provide Significant Growth Opportunities to Market Players
11.3 Biochemical Assays
11.3.1 Assays are Majorly Used in the Pharmaceutical Industry to Quantify Biological Activities in Drug Development
11.4 In Silico Models
11.4.1 In Silico Models are Expected to Register the Highest CAGR During the Forecast Period
11.5 EX Vivo Models
11.5.1 EX Vivo Models are Widely Used in Skin & Eye Toxicity Testing in the Cosmetic Industry
12 In Vitro Toxicology Testing Market, By Region (Page No. – 108)
12.1 Introduction
12.2 Europe
12.2.1 Germany
12.2.1.1 Germany Holds the Largest Share of the European Market
12.2.2 UK
12.2.2.1 Rising Awareness, Growing R&D, and Increasing Collaborations are Key Indicators of Market Growth in the UK
12.2.3 France
12.2.3.1 Research Initiatives Supported By the Government are Aiding Market Growth in France
12.2.4 Italy
12.2.4.1 Growth in This Market is Mainly Driven By the Increasing Life Science R&D
12.2.5 Spain
12.2.5.1 Spain’s Growing Chemical Industry is A Major Factor Supporting Its In Vitro Toxicology Testing Market
12.2.6 Rest of Europe
12.3 North America
12.3.1 US
12.3.1.1 US Dominates the North American Market
12.3.2 Canada
12.3.2.1 Strong Support for R&D and Focus on Developing New Therapies Will Support Market Growth in Canada
12.4 Asia Pacific
12.4.1 China
12.4.1.1 Increasing International Pressure to Ban Animal Testing Methods Will Propel Market Growth in the Coming Years
12.4.2 Japan
12.4.2.1 Use of Artificial Skin Patches and Plates of Cultured Human Cells has Increased in Japan
12.4.3 India
12.4.3.1 Growing Crams Industry and the Ban on the Use of Animals in Cosmetics and Universities are Likely to Propel Market Growth
12.4.4 Rest of Asia Pacific
12.5 Latin America
12.5.1 Low Cost of Drug Trials have Made Latin America A Popular Outsourcing Market
12.6 Middle East & Africa
12.6.1 Increasing R&D Investments and Focus on the Development of New Drugs are Contributing to Market Growth
13 Competitive Landscape (Page No. – 173)
13.1 Overview
13.2 Market Share Analysis
13.3 Competitive Leadership Mapping
13.3.1 Visionary Leaders
13.3.2 Innovators
13.3.3 Dynamic Differentiators
13.3.4 Emerging Companies
13.4 Competitive Situation and Trends
13.4.1 Product & Service Launches
13.4.2 Expansions
13.4.3 Acquisitions
13.4.4 Other Strategies
14 Company Profiles (Page No. – 183)
14.1 Thermo Fisher Scientific, Inc.
14.2 Merck KGaA
14.3 Eurofins Scientific Se
14.4 GE Healthcare
14.5 Covance, Inc.
14.6 Charles River Laboratories International, Inc.
14.7 SGS S.A.
14.8 Bio-Rad Laboratories, Inc.
14.9 Qiagen N.V.
14.10 Cyprotex PLC
14.11 Promega Corporation
14.12 Catalent, Inc.
14.13 Gentronix Limited
14.14 MB Research Laboratories
14.15 Bioivt
14.16 Creative Biolabs
14.17 GVK Biosciences Private Limited
14.18 Shanghai Medicilon Inc.
14.19 Creative Bioarray
14.20 Insphero
15 Appendix (Page No. – 243)
15.1 Insights of Industry Experts
15.2 Discussion Guide
15.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
15.4 Available Customizations
15.5 Related Reports
15.6 Author Details

関連データはありません。

※当サイトのレポート紹介カバレッジ
■産業：医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域：世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類：市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様